Christopher M. Bral

Discovery of a Novel, First-in-Class, Orally Bioavailable Azaindole Inhibitor (VX-787) of Influenza PB2

Michael P. Clark, Mark W. Ledeboer, Ioana Davies et al. · Journal of Medicinal Chemistry · 2014 · 207 citations · Full text

Influenza Pb2, Medicinal Chemistry, Medicine +13

Quantitative gene expression analysis in a nonhuman primate model of antibiotic-induced nephrotoxicity

John W. Davis, Federico Goodsaid, Christopher M. Bral et al. · Toxicology and Applied Pharmacology · 2004 · 63 citations

Nonhuman Primate Model, Antimicrobial Resistance Gene, Antimicrobial Susceptibility +9

Identification of Benzo[a]pyrene-InducibleCis-Acting Elements Within c-Ha-rasTranscriptional Regulatory Sequences

Christopher M. Bral, Kenneth S. Ramos · Molecular Pharmacology · 1997 · 48 citations

Benzo(a)pyrene-Induced Alterations in Growth-Related Gene Expression and Signaling in Precision-Cut Adult Rat Liver and Kidney Slices

Alan Parrish, Robyn L. Fisher, Christopher M. Bral et al. · Toxicology and Applied Pharmacology · 1998 · 44 citations

Medicine, Liver Physiology, Pyrene-induced Alterations +9

Profiles of antioxidant/electrophile response element (ARE/EpRE) nuclear protein binding and c-Ha-ras transactivation in vascular smooth muscle cells treated with oxidative metabolites of benzo[a]pyrene

Kimberly P. Miller, Yun-Houng Chen, Victoria L Hastings et al. · Biochemical Pharmacology · 2000 · 24 citations

C-ha-ras Transactivation, Biochemistry, Medicine +10